Certificate Under Regulation 40(9) Of SEBI(LODR), Regulations, 2015
Certificate under Regulation 40(9) of SEBI(LODR), Regulations, 2015 signed by PCS Mr. P.D. Sharma, partner of M/s. Sharma Sarin & Associates.21-04-2017
21-04-2017
Compliance Certificate For The Period Ended 31.03.2017
Compliance Certificate under Regulation 7(3) of SEBI(LODR),Regulations, 2015 for the period ended 31.03.2017 signed by RTA and Compliance Officer of the Company.12-04-2017
Statement Of Investor Grievances For The Quarter Ended 31.03.2017
Statement of Investor Grievances for the quarter ended 31.03.201707-04-2017
Shareholding for the Period Ended March 31, 2017
Brooks Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click here07-04-2017
Updates
Commencement of Commercial Production at our New Manufacturing Unit-II, Vadodara, Gujarat.07-03-2017
Standalone Financial Results, Limited Review Report for December 31, 2016
Brooks Laboratories Ltd has informed BSE about : 1. Standalone Financial Results for the period ended December 31, 20162. Standalone Limited Review for the period ended December 31, 201614-02-2017
Board Meeting Intimation for Results & Closure of Trading Window
Brooks Laboratories Ltd has informed BSE that a Meeting of Board of Directors of the Company is scheduled to be held on February 14, 2017, inter alia, to consider and approve Unaudited Financial Results of the Company, for the 3rd quarter ended December 31, 2016.Pursuant to this, the Company has decided that the close period (i.e. closure of trading window) for Insiders covered under "Code of Conduct for Prohibition of Insider Trading" of...06-02-2017
Credit Rating
Brooks Laboratories Ltd has informed BSE that the Company has received credit rating by CARE Ratings for Long Term and Short Term Bank facilities.20-01-2017
Shareholding for the Period Ended December 31, 2016
Brooks Laboratories Ltd has submitted to BSE the Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click here12-01-2017
Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
Brooks Laboratories Ltd has informed BSE regarding Quarterly Statement on Investor Complaints / Grievances Redressal Mechanism for the Quarter ended December 31, 2016, under Regulation 13(3) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015.07-01-2017